XVA-33307-68503
2 vaccinations
7 coded responses
30 check-ins
7 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 440 / OH
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Registered in v-safe
-
2021-03-09
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-09
-
2021-03-10
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-23
- 2021-04-01
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-06-08
-
2021-09-07
Survey response — 6 month, dose 1MedDRA: Dehydration, Dizziness, Rhinorrhoea, Sensitivity to weather change — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2021-12-09
Dose 2 — ModernaCo-administered: Flu
-
2021-12-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-12-11
- 2021-12-12
- 2021-12-13
-
2021-12-14
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2021-12-15
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2021-12-16
Survey response — 7 day, dose 2MedDRA: Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
- 2021-12-23
-
2021-12-30
Survey response — 21 day, dose 2MedDRA: Office visit, Rhinorrhoea, Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11 · check-in answers available
-
2021-12-30
Report sent to call center — 21 day, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2022-01-05
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-03-10
- 2022-06-09
-
2022-12-09
Survey response — 12 month, dose 2MedDRA: COVID-19, Quarantine, Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-09 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-30 | Successful 2022-01-05 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 5
Systemic reaction (other): No
Release 9
Symptoms: Had an episode of dizziness probably due heat and dehydration and i dont believe this is related to the vaccination. I have noticed that I seem to have a runny nose more frequently since having the vaccination. Its nothing Im overly concern
Release 10
Systemic reaction (other): Runny nose on and off for the last few days
Systemic reaction (other): Runny nose this morning
Systemic reaction (other): Very slight runny nose this morning
Symptoms: Urinary tract infection Runny nose more often
Healthcare visit (other): Doctors office visit
Release 12
Symptoms: Had COVID from 11/27/22 to 12/6/22 Mild symptoms just a runny nose Quarantined for ten days and Treated with decongestant
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dehydration | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sensitivity to weather change | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release